Skip to main content

August 2012 Vol 5, No 5, Special Issue ASCO 2012 Payers' Perspective

Renal-Cell Carcinoma
First-Line Treatments for Metastatic Renal-Cell Carcinoma Are Evolving
Read More
Renal-Cell Carcinoma
Tivozanib Outperforms Sorafenib as First-Line Treatment in Advanced Renal-Cell Carcinoma
Read More
Prostate Cancer
In Head-to-Head Comparison, Continuous Beats Intermittent Hormonal Therapy for Metastatic Prostate Cancer
Wayne Kuznar
Read More
Breast Cancer
Chemotherapy-Related Toxicity Adds to Economic Burden in Metastatic Breast Cancer
Caroline Helwick
Read More
Prostate Cancer
A Promising New Gene Test to Differentiate Between Aggressive and Indolent Disease
Wayne Kuznar
Read More
Multiple Myeloma
Pomalidomide Shows Strong Activity in Relapsed/Refractory Myeloma
Caroline Helwick
Read More
Prostate Cancer
Agent that Targets Heat Shock Protein Shows Activity in Castration-Resistant Prostate Cancer
Wayne Kuznar
Read More
Multiple Myeloma
First Oral Proteasome Inhibitor Active in Myeloma
Read More
Prostate Cancer
Abiraterone Before Chemotherapy a Successful Strategy in Prostate Cancer
Wayne Kuznar
Read More
Molecular Profiling Guiding Cancer Therapy
Caroline Helwick
Read More
Page 1 of 4
Results 1 - 10 of 33